PMH14 THE COST-EFFECTIVENESS OF QUETIAPINE EXTENDED-RELEASE VERSUS OLANZAPINE FOLLOWING GENERIC RISPERIDONE IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66914-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)66914-8/fulltext
Title :
PMH14 THE COST-EFFECTIVENESS OF QUETIAPINE EXTENDED-RELEASE VERSUS OLANZAPINE FOLLOWING GENERIC RISPERIDONE IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66914-8&doi=10.1016/S1098-3015(10)66914-8
First page :
Section Title :
Open access? :
No
Section Order :
749